共 48 条
[1]
Mancuso MR(2017)Novel sustemic therapy against malignant pleural mesothelioma Transl Lung Cancer Res 6 295-314
[2]
Neal JW(2007)Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument Ann Surg Oncol 14 1249-1253
[3]
Cameron RB(2011)Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma ond radical surgery (MARS) randomized feasibility study Lancet Oncol 12 763-772
[4]
Treasure T(2012)Initial analysis of the international association for the study of lung cancer mesothelioma database J Thorac Oncol 7 1632-1639
[5]
Lang-Lazdunski L(2008)Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients J Thorac Cardiovasc Surg 135 620-626
[6]
Waller D(2018)New perspectives on diagnosis and therapy of malignant pleural mesothelioma Front Oncol 8 91-658
[7]
Bliss JM(2018)Non-incisional pleurectomy-decortication for malignant pleural mesothelioma Surg Today 48 656-2351
[8]
Tan C(2014)Long progeression-free survival by pemetrexed continuation maintenance thrapy following cisplatin-based chemotherapy in malignant pleural mesothelioma Intern Med 53 2347-undefined
[9]
Entwisle J(2016)Pemetrexed maintenance therapy following bevacizumab-containing first-line chemotherapy in advanced maliganant pleural mesothelioma Medicine 95 e3351-undefined
[10]
Rusch VW(2018)A phase II trial of first-line combination chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for unresectable malignant pleural mesothelioma: a study protocol Clin Lung Cancer 19 e705-7-undefined